Authors: Kanerva, H Vilkman, H Nagren, K Kilkku, O Kuoppamaki, M Syvalahti, E Hietala, J

Citation: H. Kanerva et al., Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study, PSYCHOPHAR, 145(1), 1999, pp. 76-81

Authors: Kanerva, H Kilkku, O Helminen, A Rouru, J Scheinin, M Huupponen, R Klebovich, I Drabant, S Urtti, A

Citation: H. Kanerva et al., Pharmacokinetics and safety of deramciclane during multiple oral dosing, INT J CL PH, 37(12), 1999, pp. 589-597

Authors: Kanerva, H Kilkku, O Heinonen, E Helminen, A Rouru, J Tarpila, S Scheinin, M Huupponen, R Klebovich, I Drabant, S Urtti, A

Citation: H. Kanerva et al., The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers, BIOPHARM DR, 20(7), 1999, pp. 327-334

Authors: Aaltonen, H Kilkku, O Heinonen, E Maki-Ikola, O

Citation: H. Aaltonen et al., Effect of adding selegiline to levodopa in early, mild Parkinson's disease- Evidence is insufficient to show that combined treatment increases mortality, BR MED J, 317(7172), 1998, pp. 1586-1587